Dear Research Advocate: This morning, the Senate Commerce, Science, and Transportation Committee held a hearing with Dr. Kelvin Droegemeier, the nominee for director of the White House Office of Science and Technology Policy (OSTP). Committee Chairman John Thune (R-SD) said Dr. Droegemeier is eminently well qualified to lead OSTP and he hopes for a speedy confirmation. Use this editable email to reinforce that sentiment with your Senators! You can read Dr. Droegemeier’s testimony for the hearing here . Also in the Senate today, the Senate Health, Education, Labor and Pensions (HELP) Committee held a hearing on "Prioritizing Cures: Science and Stewardship at the National Institutes of Health...

Dear Research Advocate: With the recent nomination of atmospheric scientist Kelvin Droegemeier, PhD, to head the White House Office of Science and Technology Policy (OSTP), I have been asked about the role of this office and its director. In this terrific analysis , Former OSTP assistant director Tom Kalil lays it all out and also offers compelling observations on the nature of effective leadership. Anyone interested in public service, policy-making or policy-influencing, and/or honing leadership skills, would do well to spend a few minutes with “Policy Entrepreneurship at the White House.” Research!America sent a letter to Senate Commerce, Science, Transportation Committee Chair John Thune...

Before the 20 th century, the only way to become immune to ailments like measles, smallpox, and diphtheria was to develop naturally acquired immunity – to contract a disease and hopefully survive it to prevent future infection. The development of vaccines revolutionized care for these diseases, and smallpox and diphtheria have since been eradicated in the United States while cases of measles are down 99.9% since the measles vaccine was introduced in 1963. August marks National Immunization Awareness Month, during which health care providers, researchers, and patient advocates join forces to inform the public on the health benefits of vaccines as well as advancements in vaccine research. A...

Around one in five American adults lives with a mental illness, such as depression, bipolar disorder, or an anxiety disorder, according to the National Institute of Mental Health. Many of these people also have serious, often preventable, physical illnesses, but often don’t get the care they need for those problems. As a result, people with serious mental illnesses die on average 10 to 20 years earlier than others. These illnesses affect minority communities to a substantially greater degree than they do non-Hispanic white populations. Due to the stigma associated with mental illness, difficulty accessing effective treatments and qualified providers, and a lack of clear evidence to support...